Brought to you by 
Stryker to distribute Etex's bone graft substitutes
23 Jul 2010
Executive Summary
Biomaterials firm Etex Corp. has licensed Stryker Corp.'s spine division non-exclusive rights to market and distribute its FDA-approved Bio MatrX Structure and Bio MatrX Generate bone graft substitutes.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Stryker to distribute Etex's bone graft substitutes
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice